Autopsy report · NCT04441385

Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“lack of viability”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 7 months before it stopped.
60 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 2
Sponsor: Hospital Universitario Infanta Leonor
Sponsor type: University, hospital or other
Conditions: COVID-19
Interventions: Maraviroc 300 mg; Standard care therapy
Participants: 60
Sites: 2
Countries: Spain

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.